Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.

Exclusive: Strand lays off 18% of staff as its first mRNA therapies head into the clinic

Less than a week after announcing that regulators have greenlit the first tests of its tumor-busting mRNA therapy, Strand Therapeutics has laid off roughly 18%

January 27, 2024

Latest COVID-19 booster halves risk of moderate or severe disease in adults

The most recent COVID-19 booster shot reduces adults’ risk of moderate or severe COVID by more than half, according to a new nationwide data study

March 1, 2024

Researchers develop new method for mapping how the parts of the brain “speak” to each other

A research team led by Cleveland Clinic and Oregon Health and Science University (OHSU) has developed a new method for mapping how the parts of

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.